【摘要】：目的 探討經(jīng)尿道腔鏡技術(shù)在治療精囊腺疾病所致難治性血精中的臨床效果和優(yōu)越性。 方法 本研究選擇從2012.2-2014.2在中南大學(xué)湘雅醫(yī)院門(mén)診就診的精囊腺所致難治性血精疾病患者50例,按患者主觀要求分為手術(shù)治療組和保守治療組。并分別在治療前和治療后第1、3、6、12個(gè)月,記錄精液中的白細(xì)胞、紅細(xì)胞計(jì)數(shù)、主觀血精發(fā)生率和生活質(zhì)量評(píng)分；采用SPSS21.0for windows統(tǒng)計(jì)軟件進(jìn)行分析,檢驗(yàn)比較每組治療前后的情況,以P0.05為有統(tǒng)計(jì)學(xué)意義。 結(jié)果 1.兩組患者治療后3、6月與治療前的各項(xiàng)主、客觀指標(biāo)相比均有顯著性(P0.05),而手術(shù)治療組在治療后1年與治療后6月的各項(xiàng)主、客觀指標(biāo)不具有顯著性(P0.05)。 2.在治療后3、6、12月各項(xiàng)主、客觀指標(biāo)改善程度方面手術(shù)組明顯優(yōu)越于保守治療組,且差異有統(tǒng)計(jì)學(xué)意義(P0.05)。而兩組在治療后1月的主、客觀指標(biāo)改善程度差異不顯著(P0.05)。 結(jié)論 1.經(jīng)尿道精囊鏡手術(shù)和保守綜合治療均能對(duì)由精囊腺疾病所致的難治性血精癥狀的患者有一定程度的治療及改善癥狀的作用。 2.就整體效果而言,經(jīng)尿道精囊鏡手術(shù)要明顯優(yōu)于保守綜合治療,可作為單純藥物改善不佳時(shí)的一種很好的補(bǔ)充治療手段。
[Abstract]:Objective to investigate the clinical effect and superiority of transurethral endoscopic technique in the treatment of intractable hemospermia caused by seminal vesicle gland disease. Methods 50 patients with intractable hemospermia caused by seminal vesicle in Xiangya Hospital of Central South University from February to April 2012.were divided into surgical treatment group and conservative treatment group according to the subjective requirements of the patients. The white blood cells (WBC), red blood cell count (RBC), subjective blood spermatozoa incidence and quality of life (QOL) were recorded before and 6 and 12 months after treatment. SPSS21.0for windows statistical software was used to analyze and compare the status of each group before and after treatment, with P0.05 as statistical significance. Result 1. There were significant differences in subjective and objective indexes between 3 and 6 months after treatment in both groups (P0.05), but there was no significant difference in subjective and objective indexes in surgical treatment group in 1 year after treatment and 6 months after treatment (P0.05). 2. The degree of improvement of subjective and objective indexes in the operation group was significantly better than that in the conservative treatment group after 3 months and 12 months, and the difference was statistically significant (P0.05). There was no significant difference in the improvement of subjective and objective indexes between the two groups in 1 month after treatment (P0.05). Conclusion 1. Both transurethral seminal vesicle surgery and conservative comprehensive therapy can treat and improve the symptoms of intractable hemospermia caused by seminal vesicle diseases to a certain extent. 2. As far as the overall effect is concerned, transurethral seminal vesicle surgery is superior to conservative comprehensive therapy, and can be used as a good supplementary treatment for the poor improvement of simple drugs.
【學(xué)位授予單位】：中南大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類(lèi)號(hào)】：R697.4

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 朱峰;張艷;劉沛;張會(huì)清;張英杰;;經(jīng)尿道輸尿管鏡技術(shù)診治血精28例臨床分析[J];中國(guó)內(nèi)鏡雜志;2012年09期

，

本文編號(hào)：2376914